Ildiko Lingvay, MD
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) with University of Texas Southwestern Medical Center at Dallas, practicing in Dallas, Texas. Their prescriptions cost Medicare Part D more than their services did: $76,488 for 234 claims, against $4,353 paid for services in 2024. Boehringer Ingelheim Pharmaceuticals, Inc. was the largest of 16 companies reporting payments in 2025, $170,873 in all, mostly consulting fees. Lists Parkland Health & Hospital System and 1 other hospital as hospital affiliations.
Overview
| NPI | 1447216916 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 25, 2006 |
| Last updated in NPPES | Feb 6, 2008 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | L5435 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 32 |
|---|---|
| Services billed | 49 across 11 procedure codes |
| Paid by Medicare | $4,353 |
Part D prescriptions in 2024
| Prescriptions (claims) | 234 · 586 30-day fills |
|---|---|
| Patients | 48 |
| Total drug cost | $76,488 |
Education and affiliations
| Graduation year | 1998 |
|---|---|
| Medicare specialty | Endocrinology |
| Secondary specialties | Internal Medicine |
Medical group
- University of Texas Southwestern Medical Center at DallasDallas, TX · 3,187 clinicians
Hospital affiliations
Industry payments (Open Payments)
- 2025$170,873 · 115 payments from 16 companies
- 2024$129,962 · 109 payments from 13 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $43,817 | 43 |
| Novo Nordisk As | $32,016 | 22 |
| F. Hoffmann-La Roche Ag | $18,341 | 8 |
| Pfizer Inc. | $18,288 | 7 |
| Genentech, Inc. | $15,648 | 7 |
What the 2025 payments were for
- Consulting Fee$138,023 · 44 payments
- Travel and Lodging$29,796 · 36 payments
- Food and Beverage$1,805 · 34 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$1,249 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Dallas
- 1538320072
- 1245696806
- 1619090222
- 1457861825
- 1306890736
- 1891718011
- 1518288596
- 1659301380
- 1518146935
- 1336350032
- 1932382249
- 1376288670
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →